U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute

U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute — Live Feedhttps://www.live-feeds.com/feed/u-s-court-orders-guardant-to-pay-245-million-in-dna-sequencing-patent-disputeContinuously updated, source-cited coverage. Guardant ordered to pay $245 million in DNA sequencing patent disputehttps://www.live-feeds.com/feed/u-s-court-orders-guardant-to-pay-245-million-in-dna-sequencing-patent-disputehttps://www.live-feeds.com/feed/u-s-court-orders-guardant-to-pay-245-million-in-dna-sequencing-patent-dispute#u48527Wed, 26 Aug 2026 00:06:57 +0000A US court has ordered Guardant Health to pay $245 million in a DNA sequencing patent dispute with TwinStrand Biosciences and the University of Washington. The dispute centred on patent infringement claims. Guardant plans to appeal the ruling.Why it mattersThis ruling marks a significant development in the ongoing patent dispute between Guardant Health and TwinStrand Biosciences, a company focused on advancing cancer research through innovative genomic solutions. The case highlights the competitive and litigious nature of the genetic testing and sequencing industry. Guardant Health is a leadin